This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Vosevi
  • /
  • Safety and Efficacy of SOF/VEL/VOX FDC for 12 Week...
Clinical trial

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

Read time: 3 mins
Last updated:1st Dec 2015
Identifier: NCT02639247
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest